Bioventus (BVS) Other Working Capital Changes (2021 - 2026)

Bioventus (BVS) has reported Other Working Capital Changes for 7 consecutive years, with $170000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Working Capital Changes fell 55.5% year-over-year to $170000.0; the trailing twelve-month figure through Jun 2026 stood at $843000.0 (down 67.73% YoY), and the FY2025 full-year result was $1.2 million, down 58.68% from the prior year.
• Other Working Capital Changes retreated to $170000.0 in Q2 2026 per BVS's latest filing, from $275000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $7.4 million in Q4 2024 and bottomed at -$8.3 million in Q4 2022.
• Historically, Other Working Capital Changes has averaged -$277611.1 across 5 years, with a median of -$329000.0 in 2023.
• The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes soared 346.34% in 2023, then sank 87.61% in 2025.
• Over 5 years, Other Working Capital Changes stood at $222000.0 in 2022, then jumped by 37.84% to $306000.0 in 2023, then surged by 308.82% to $1.3 million in 2024, then tumbled by 87.61% to $155000.0 in 2025, then gained by 9.68% to $170000.0 in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered $170000.0, $275000.0, and $155000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.